Advanced glycation end products

Aging is the progressive accumulation of damage to an organism over time leading to disease and death. Aging research has been very intensive in the last years aiming at characterizing the pathophysiology of aging and finding possibilities to fight age-related diseases. Various theories of aging have been proposed. In the last years advanced glycation end products (AGEs) have received particular attention in this context. AGEs are formed in high amounts in diabetes but also in the physiological organism during aging. They have been etiologically implicated in numerous diabetes- and age-related diseases. Strategies inhibiting AGE accumulation and signaling seem to possess a therapeutic potential in these pathologies. However, still little is known on the precise role of AGEs during skin aging. In this review the existing literature on AGEs and skin aging will be reviewed. In addition, existing and potential anti-AGE strategies that may be beneficial on skin aging will be discussed.

[1]  K. Wittern,et al.  Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. , 2007, The Journal of biological chemistry.

[2]  S. Yamagishi,et al.  Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. , 2007, Current pharmaceutical design.

[3]  S. Rattan,et al.  Sugar‐Induced Premature Aging and Altered Differentiation in Human Epidermal Keratinocytes , 2007, Annals of the New York Academy of Sciences.

[4]  L. Ferrucci,et al.  Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  V. P. Reddy,et al.  Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. , 2006, Drug discovery today.

[6]  A. Smit,et al.  Simple Noninvasive Measurement of Skin Autofluorescence , 2005, Annals of the New York Academy of Sciences.

[7]  C. Oh,et al.  Quantitative measurement of desquamation and skin elasticity in diabetic patients , 2002, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[8]  S. Genuth,et al.  Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.

[9]  H. Founds,et al.  Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. , 2003, Archives of biochemistry and biophysics.

[10]  J. Baynes,et al.  AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats. , 2003, Archives of biochemistry and biophysics.

[11]  V. Monnier,et al.  Prevention and repair of protein damage by the Maillard reaction in vivo. , 2006, Rejuvenation research.

[12]  M. Brownlee,et al.  Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine , 1992, Diabetes.

[13]  R. G. Paul,et al.  Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. , 1996, The international journal of biochemistry & cell biology.

[14]  L. Ferrucci,et al.  Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. , 2009, Seminars in nephrology.

[15]  D. Asselineau,et al.  Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules , 2008, Experimental Gerontology.

[16]  V. Monnier,et al.  Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  V. Monnier,et al.  Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. , 1989, Connective tissue research.

[18]  Li Yan,et al.  Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA , 2011, Archives of Dermatological Research.

[19]  G. Yen,et al.  Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. , 2005, Journal of agricultural and food chemistry.

[20]  Paul J Thornalley,et al.  Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. , 2012, The Biochemical journal.

[21]  A. Smit,et al.  Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. , 2006, Diabetes technology & therapeutics.

[22]  J. Bijlsma,et al.  Age-related accumulation of Maillard reaction products in human articular cartilage collagen. , 2000, The Biochemical journal.

[23]  R. Bank,et al.  Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. , 2001, Arthritis and rheumatism.

[24]  V. Monnier,et al.  ELISA of pentosidine, an advanced glycation end product, in biological specimens. , 1994, Clinical chemistry.

[25]  H. Corstjens,et al.  Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes. , 2012, Diabetes technology & therapeutics.

[26]  G. Striker,et al.  AGE restriction in diabetes mellitus: a paradigm shift , 2011, Nature Reviews Endocrinology.

[27]  J. Hargrove,et al.  Inhibition of protein glycation by extracts of culinary herbs and spices. , 2008, Journal of medicinal food.

[28]  Danielle T. Loughlin,et al.  Precursor of Advanced Glycation End Products Mediates ER-Stress-Induced Caspase-3 Activation of Human Dermal Fibroblasts through NAD(P)H Oxidase 4 , 2010, PloS one.

[29]  C. Zouboulis,et al.  William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. , 2007, Dermatology.

[30]  K. Šebeková,et al.  Dietary advanced glycation endproducts (AGEs) and their health effects--PRO. , 2007, Molecular nutrition & food research.

[31]  M. Yamauchi,et al.  Collagen cross-linking in sun-exposed and unexposed sites of aged human skin. , 1991, The Journal of investigative dermatology.

[32]  N. Ahmed,et al.  Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. , 2012, Current diabetes reviews.

[33]  A. Schmidt,et al.  Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. , 1993, The Journal of clinical investigation.

[34]  M. Boulton,et al.  Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  J. DeGroot.  The AGE of the matrix: chemistry, consequence and cure. , 2004, Current opinion in pharmacology.

[36]  C. K. Lee,et al.  Gene expression profile of aging and its retardation by caloric restriction. , 1999, Science.

[37]  A. N. Anbazhagan,et al.  Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-α and matrix metalloproteinase-13 in human chondrocytes , 2009, Arthritis research & therapy.

[38]  Takashi Kobayashi,et al.  AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis. , 2010, The Journal of investigative dermatology.

[39]  V. D’Agati,et al.  Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. , 2003, Archives of biochemistry and biophysics.

[40]  A. Jenkins,et al.  Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes , 2006, Diabetologia.

[41]  A. Schmidt,et al.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.

[42]  P. Nawroth,et al.  Reactive Metabolites and AGE/RAGE-Mediated Cellular Dysfunction Affect the Aging Process – A Mini-Review , 2010, Gerontology.

[43]  M. Babizhayev,et al.  Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products. , 2010, Critical reviews in therapeutic drug carrier systems.

[44]  Kyung-Hyun Cho,et al.  Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[45]  J. Uribarri,et al.  Advanced glycoxidation end products in commonly consumed foods. , 2004, Journal of the American Dietetic Association.

[46]  K. Herold,et al.  RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation1 , 2008, The Journal of Immunology.

[47]  D. Bernhard,et al.  Cigarette smoke – an aging accelerator? , 2007, Experimental Gerontology.

[48]  A. Kawada,et al.  N(ɛ)-(carboxymethyl)lysine modification of elastin alters its biological properties: implications for the accumulation of abnormal elastic fibers in actinic elastosis. , 2012, The Journal of investigative dermatology.

[49]  Hiroshi Yamamoto,et al.  The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[50]  H. Vlassara.  The AGE‐receptor in the pathogenesis of diabetic complications , 2001, Diabetes/metabolism research and reviews.

[51]  J. Baynes,et al.  Role of the Maillard Reaction in Aging of Tissue Proteins , 1998, The Journal of Biological Chemistry.

[52]  B. Grad.  Theories of ageing. , 1959, Excerpta medica. Section 20, Gerontology and geriatrics.

[53]  E. Menzel,et al.  Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation. , 2000, Clinical biomechanics.

[54]  M. Peppa,et al.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Robert,et al.  Expression of senescence-associated beta-galactosidase (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and fucose or rhamnose-rich polysaccharides. , 2009, Archives of gerontology and geriatrics.

[56]  W. A. Johnson,et al.  Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Vinson,et al.  Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients , 1996 .

[58]  Paul J Thornalley.  The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept. , 2003, Biochemical Society transactions.

[59]  D. Harman.  Free radical theory of aging. , 2003, Mutation research.

[60]  Takafumi Inoue,et al.  The presence of N(ε)-(Carboxymethyl) lysine in the human epidermis. , 2011, Biochimica et biophysica acta.

[61]  K. Ikeda,et al.  Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. , 1997, The Journal of investigative dermatology.

[62]  C. Anuradha,et al.  Lipoic acid prevents collagen abnormalities in tail tendon of high‐fructose‐fed rats , 2005, Diabetes, obesity & metabolism.

[63]  M. Steffes,et al.  Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. , 2002, Kidney international.

[64]  Cheolju Lee,et al.  Protein Glycation , 2001, Annals of the New York Academy of Sciences.

[65]  L. Maillard,et al.  Action des acides amines sur les sucres : formation des melanoidines par voie methodique , 1912 .

[66]  J. Baynes,et al.  Maillard reaction products in tissue proteins: New products and new perspectives , 2003, Amino Acids.

[67]  D. L. Price,et al.  Chelating Activity of Advanced Glycation End-product Inhibitors* , 2001, The Journal of Biological Chemistry.

[68]  James Varani,et al.  Mechanisms of photoaging and chronological skin aging. , 2002, Archives of dermatology.

[69]  Li Yan,et al.  Involvement of RAGE, MAPK and NF‐κB pathways in AGEs‐induced MMP‐9 activation in HaCaT keratinocytes , 2012, Experimental dermatology.

[70]  H Pageon,et al.  Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. , 2010, Pathologie-biologie.

[71]  H. Ukeda,et al.  Inactivation of Cu,Zn-superoxide dismutase by intermediates of Maillard reaction and glycolytic pathway and some sugars. , 1997, Bioscience, biotechnology, and biochemistry.

[72]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Nègre-Salvayre,et al.  Advanced glycation end product precursors impair epidermal growth factor receptor signaling. , 2002, Diabetes.

[74]  P. Farris.  Innovative cosmeceuticals: sirtuin activators and anti-glycation compounds. , 2011, Seminars in cutaneous medicine and surgery.

[75]  V. Monnier,et al.  Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[76]  D. Stern,et al.  Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.

[77]  Z. Medvedev.  AN ATTEMPT AT A RATIONAL CLASSIFICATION OF THEORIES OF AGEING , 1990, Biological reviews of the Cambridge Philosophical Society.

[78]  J. Hodge.  Dehydrated Foods, Chemistry of Browning Reactions in Model Systems , 1953 .

[79]  Nessar Ahmed,et al.  Advanced glycation endproducts--role in pathology of diabetic complications. , 2005, Diabetes research and clinical practice.

[80]  B. Hudson,et al.  Pyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor , 2005, Annals of the New York Academy of Sciences.

[81]  J. Baynes,et al.  N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. , 1995, Biochemistry.

[82]  V. Monnier,et al.  Enzymatic deglycation with amadoriase enzymes from Aspergillus sp. as a potential strategy against the complications of diabetes and aging. , 2003, Biochemical Society transactions.

[83]  Z. Draelos,et al.  An evaluation of the effect of a topical product containing C‐xyloside and blueberry extract on the appearance of type II diabetic skin , 2009, Journal of cosmetic dermatology.

[84]  Suresh I. S. Rattan,et al.  Dicarbonyl-induced accelerated aging in vitro in human skin fibroblasts , 2009, Biogerontology.

[85]  Paul J Thornalley,et al.  Glyoxalase in ageing. , 2011, Seminars in cell & developmental biology.

[86]  M. Brownlee,et al.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. , 1994, The Journal of clinical investigation.

[87]  S. Grabbe,et al.  Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells , 2010, Immunology.

[88]  D. Kass,et al.  Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. , 2004, American journal of hypertension.

[89]  Paul J Thornalley,et al.  Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. , 1998, The Journal of clinical investigation.

[90]  G. Wondrak,et al.  Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins. , 2002, The Journal of investigative dermatology.

[91]  R. Bucala,et al.  Tobacco smoke is a source of toxic reactive glycation products. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[92]  A J Bailey,et al.  The effects of the Maillard reaction on the physical properties and cell interactions of collagen. , 2006, Pathologie-biologie.

[93]  V. Velebný,et al.  Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts , 2008, Biogerontology.

[94]  T. Trappe,et al.  Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. , 2007, Journal of applied physiology.

[95]  D. Graves,et al.  Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways* , 2005, Journal of Biological Chemistry.

[96]  J. Baynes.  The Maillard Hypothesis on Aging: Time to Focus on DNA , 2002, Annals of the New York Academy of Sciences.

[97]  B. Szwergold,et al.  Some Clues as to the Regulation, Expression, Function, and Distribution of Fructosamine‐3‐Kinase and Fructosamine‐3‐Kinase‐Related Protein , 2005, Annals of the New York Academy of Sciences.

[98]  A. Smit,et al.  Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease , 2010, Current opinion in nephrology and hypertension.

[99]  Dong Ho Jung,et al.  Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. , 2012, Experimental cell research.

[100]  G. Wondrak.  Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. , 2007, Current opinion in investigational drugs.

[101]  Alan W. Stitt,et al.  Increased Levels of Advanced Glycation Endproducts in the Lenses and Blood Vessels of Cigarette Smokers , 1998, Molecular medicine.

[102]  T. Lyons,et al.  Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. , 1991, Biochemistry.

[103]  M. Babizhayev,et al.  Biologic Activities of Molecular Chaperones and Pharmacologic Chaperone Imidazole-Containing Dipeptide-Based Compounds: Natural Skin Care Help and the Ultimate Challenge. Implication for Adaptive Responses in the Skin , 2012, American journal of therapeutics.

[104]  E. Tsilibary,et al.  Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. , 1992, The Journal of biological chemistry.

[105]  E. Schaftingen,et al.  Enzymatic repair of Amadori products , 2010, Amino Acids.

[106]  M. Halushka,et al.  Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysis. , 2010, Free radical biology & medicine.

[107]  J. He,et al.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[108]  V. Monnier,et al.  Enzymatic deglycation of proteins. , 2003, Archives of biochemistry and biophysics.

[109]  T. Kislinger,et al.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.

[110]  K. Reiser,et al.  Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. , 1994, Journal of gerontology.

[111]  H. Sakurai,et al.  Generation of active oxygen species from advanced glycation end-products (AGE) under ultraviolet light A (UVA) irradiation. , 1997, Biochemical and biophysical research communications.

[112]  T. Lyons,et al.  Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a , 1992, Annals of the New York Academy of Sciences.

[113]  Alan W. Stitt,et al.  Advanced glycation: an important pathological event in diabetic and age related ocular disease , 2001, The British journal of ophthalmology.

[114]  J. Bijlsma,et al.  Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products* , 2000, The Journal of Biological Chemistry.

[115]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Baynes,et al.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.

[117]  N. Bresolin,et al.  Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. , 1999, Science.

[118]  C. Stehouwer,et al.  Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats* , 2010, The Journal of Biological Chemistry.

[119]  P. B. Chock,et al.  Oxidation-Reduction Properties of Methylglyoxal-modified Protein in Relation to Free Radical Generation* , 1998, The Journal of Biological Chemistry.

[120]  P. Giacomoni,et al.  Factors of skin ageing share common mechanisms , 2004, Biogerontology.

[121]  R. Ramasamy,et al.  RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts , 2009, Journal of leukocyte biology.

[122]  M. Obrenovich,et al.  Green tea extract suppresses the age-related increase in collagen crosslinking and fluorescent products in C57BL/6 mice. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[123]  D. Schuppan,et al.  The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. , 2006, The Journal of investigative dermatology.

[124]  J. Baynes,et al.  N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. , 1997, The Biochemical journal.

[125]  M. Babizhayev,et al.  Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging , 2012, The Journal of dermatological treatment.

[126]  E. Schleicher,et al.  Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. , 1997, The Journal of clinical investigation.

[127]  G. Striker,et al.  Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. , 2008, The American journal of pathology.

[128]  V. Monnier,et al.  Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane , 1993, Diabetologia.

[129]  V. Monnier,et al.  Glucosepane Is a Major Protein Cross-link of the Senescent Human Extracellular Matrix , 2005, Journal of Biological Chemistry.

[130]  吉永 英司.  N[ε]-(carboxymethyl)lysine modification of elastin alters its biological properties : implications for the accumulation of abnormal elastic fibers in actinic elastosis , 2012 .

[131]  J. Eaton,et al.  Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. , 1998, Biochemical and biophysical research communications.

[132]  C. Zouboulis,et al.  Clinical aspects and molecular diagnostics of skin aging. , 2011, Clinics in dermatology.

[133]  T. Spector,et al.  Level of an advanced glycated end product is genetically determined: a study of normal twins. , 2003, Diabetes.

[134]  J. Handa,et al.  Glycation‐altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age‐related disease (in nondiabetics) , 2012, Aging cell.

[135]  S. Menini,et al.  Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. , 2003, Diabetes.

[136]  C. Jeanmaire,et al.  Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study , 2001, The British journal of dermatology.

[137]  W. Cefalu,et al.  Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[138]  R. Ramasamy,et al.  Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. , 2010, Biochemical pharmacology.

[139]  H. Seo,et al.  Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. , 1994, The Journal of clinical investigation.

[140]  H. D. de Valk,et al.  Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review. , 2011, Diabetes technology & therapeutics.

[141]  Paul J Thornalley,et al.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.

[142]  S. Vannucci,et al.  Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. , 2005, Glycobiology.

[143]  D. Dicanio,et al.  Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects , 2008, Experimental Gerontology.

[144]  S. Genuth,et al.  Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. , 2005, Diabetes.

[145]  M. Peppa,et al.  Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. , 2003, Diabetes.

[146]  E. Makrantonaki,et al.  Molecular Mechanisms of Skin Aging , 2007, Annals of the New York Academy of Sciences.

[147]  C. Zouboulis,et al.  Characteristics and Pathomechanisms of Endogenously Aged Skin , 2007, Dermatology.

[148]  Merlin C. Thomas,et al.  A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes , 2003, Circulation research.

[149]  T. Lyons,et al.  Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[150]  Vladimir Hovhannisyan,et al.  Multiphoton spectral microscopy for imaging and quantification of tissue glycation , 2010, Biomedical optics express.

[151]  V. Agte,et al.  Effect of Micronutrients on Methylglyoxal-Mediated In Vitro Glycation of Albumin , 2011, Biological Trace Element Research.